Analysis for United Therapeutics
Description & usage
United Therapeutics develops and markets therapies primarily for pulmonary arterial hypertension and related rare diseases. It benefits from specialized indications with high barriers to entry. Key valuation drivers are product sales momentum, clinical pipeline progress, patent duration, and regulatory outcomes.
Basic info
- Symbol
- UTHR
- Type
- Stock
- Region
- US
- Sector
- Health Care
- Available history
- 11.2 years
- Last trading day
- 04/02/2026
Market context
- DXY
- 120.89
- US 10Y Real
- 1.99%
- Fed Balance
- $6.68T
- CPI YoY
- 2.4%
- Fed Rate
- 3.75%
- US 10Y
- 4.35%
- VIX
- 24.54
- HY OAS
- 3.17%
- Brent
- $121.88
- Core CPI
- 2.5%
- US 2Y
- 3.84%
- ISM PMI
- –
Analysis temporarily unavailable
This asset is currently excluded from rankings and score-based analysis because the published snapshot did not pass the required data-quality checks.
Reason: Snapshot is stale
Price chart
Use the chart to read recent price behavior before drilling into metrics.
Scores and metrics
Explore the overall score, the three pillar scores, and the metrics behind them.
Explore rankings
Open the ranking view you need.
Asset types
Open rankings by asset type.
Scores
Open the four score rankings directly and see how the scores are explained.
Metrics
Open rankings by individual metrics and see what each metric means.
Countries
Open country rankings and compare how markets perform.
Data snapshot
- Snapshot as of
- Apr 02, 2026
- Last trading day
- Apr 02, 2026
- Snapshot status
- Excluded
- Data quality
- Unknown
- Exclusion reason
- Snapshot is stale
This snapshot is excluded. Unavailable values and insufficient history stay explicit instead of being treated as valid data.